1. Market Research
  2. > Healthcare Market Trends
  3. > Romania Pharmaceuticals and Healthcare Report Q4 2016

Romania Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 84 pages

Includes 3 FREE quarterly updates

BMI View:

In line with Romania's economic outperformance in Europe, the country's pharmaceutical and healthcare markets will see strong growth given increased consumer spending power and higher healthcare contributions. However, aggressive drug pricing regulations, including the imminent joint drug procurement agreement with CEE countries, will limit revenue-earning opportunities.

Headline Expenditure Projections


- Pharmaceuticals: RON14.94bn (USD3.73bn) in 2015 to RON15.89bn (USD3.76bn) in 2016; 6.4% in local currency terms and 0.7% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: RON39.05bn (USD9.75bn) in 2015 to RON41.28bn (USD9.76bn) in 2016; 5.7% in local currency terms and 0.1% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Romania Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Romania 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Romania 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 23
Generic Medicine Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 26
OTC Medicine Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Romania 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Romania 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Romania 2014-2020) 32
Pharmaceuticals and Healthcare Risk/Reward Index 33
Central And Eastern Europe Risk/Reward Index - Q4 2016 33
Romania Risk/Reward Index 40
Rewards 40
Risks 41
Regulatory Review 42
Intellectual Property Issues 42
Pricing Regime 45
Reimbursement Regime 46
Market Overview 50
Healthcare System 51
Table: Healthcare Resources (Romania 2010-2015) 55
Table: Healthcare Personnel (Romania 2010-2015) 55
Table: Healthcare Activity (Romania 2010-2015) 56
Research And Development 56
Clinical Trials 57
Epidemiology 58
Competitive Landscape 61
Research-Based Industry 61
Table: Members Of ARPIM, 2016 61
Table: Multinational Market Activity 62
Generic Drugmakers 63
Pharmaceutical Distribution 64
Pharmaceutical Retail Sector 64
Company Profile 66
Antibiotice Iasi 66
LaborMed Pharma 69
Terapia Ranbaxy 71
Demographic Forecast 73
Table: Population Headline Indicators (Romania 1990-2025) 74
Table: Key Population Ratios (Romania 1990-2025) 74
Table: Urban/Rural Population and Life Expectancy (Romania 1990-2025) 75
Table: Population By Age Group (Romania 1990-2025) 75
Table: Population By Age Group % (Romania 1990-2025) 76
Glossary 78
Methodology 80
Pharmaceutical Expenditure Forecast Model 80
Healthcare Expenditure Forecast Model 80
Notes On Methodology 81
Risk/Reward Index Methodology 82
Index Overview 83
Table: Pharmaceutical Risk/Reward Index Indicators 83
Indicator Weightings 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...

Antibody Production Market by Process, End-User - Global Forecast to 2021

Antibody Production Market by Process, End-User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The antibody production market is projected to reach USD 13.28 billion by 2021 from USD 7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.